578 related articles for article (PubMed ID: 28711608)
1. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?
Huang G; Basaria S
Mol Cell Endocrinol; 2018 Mar; 464():56-64. PubMed ID: 28711608
[TBL] [Abstract][Full Text] [Related]
2. Effects of androgenic-anabolic steroids in athletes.
Hartgens F; Kuipers H
Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
[TBL] [Abstract][Full Text] [Related]
3. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
4. Physiological basis behind ergogenic effects of anabolic androgens.
Cheung AS; Grossmann M
Mol Cell Endocrinol; 2018 Mar; 464():14-20. PubMed ID: 28159654
[TBL] [Abstract][Full Text] [Related]
5. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
Anawalt BD
Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
[TBL] [Abstract][Full Text] [Related]
6. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
Alquraini H; Auchus RJ
Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
[TBL] [Abstract][Full Text] [Related]
7. Use of performance-enhancing (and image-enhancing) drugs: A growing problem in need of a solution.
Basaria S
Mol Cell Endocrinol; 2018 Mar; 464():1-3. PubMed ID: 29426019
[No Abstract] [Full Text] [Related]
8. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
[No Abstract] [Full Text] [Related]
9. Aortic elastic properties in athletes using anabolic-androgenic steroids.
Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
[TBL] [Abstract][Full Text] [Related]
10. Anabolic-androgenic steroid dependence? Insights from animals and humans.
Wood RI
Front Neuroendocrinol; 2008 Oct; 29(4):490-506. PubMed ID: 18275992
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of anabolic steroids in athletes. A constant threat.
Maravelias C; Dona A; Stefanidou M; Spiliopoulou C
Toxicol Lett; 2005 Sep; 158(3):167-75. PubMed ID: 16005168
[TBL] [Abstract][Full Text] [Related]
12. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
Geyer H; Schänzer W; Thevis M
Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
[TBL] [Abstract][Full Text] [Related]
13. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
[TBL] [Abstract][Full Text] [Related]
14. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
Nieschlag E; Vorona E
Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
[TBL] [Abstract][Full Text] [Related]
15. Physical Effects of Anabolic-androgenic Steroids in Healthy Exercising Adults: A Systematic Review and Meta-analysis.
Andrews MA; Magee CD; Combest TM; Allard RJ; Douglas KM
Curr Sports Med Rep; 2018 Jul; 17(7):232-241. PubMed ID: 29994823
[TBL] [Abstract][Full Text] [Related]
16. Anabolic-androgenic steroids and testosterone precursors: ergogenic aids and sport.
Foster ZJ; Housner JA
Curr Sports Med Rep; 2004 Aug; 3(4):234-41. PubMed ID: 15231229
[TBL] [Abstract][Full Text] [Related]
17. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids.
Smith DA; Perry PJ
Ann Pharmacother; 1992 Apr; 26(4):520-8. PubMed ID: 1533554
[TBL] [Abstract][Full Text] [Related]
20. History and epidemiology of anabolic androgens in athletes and non-athletes.
Kanayama G; Pope HG
Mol Cell Endocrinol; 2018 Mar; 464():4-13. PubMed ID: 28245998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]